PortViewPortView
Graybug Vision logo

Graybug Vision (GRAY) Stock Analysis

NASDAQHealthcareBiotechnology

$5.50-10.80%
1-year price historyRange $2.15 – $16.52
52-week range$5.50
$4.88$20.30

What Graybug Vision does

Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical development phase, dedicated to creating treatments for conditions affecting the eye's retina and optic nerve. Its flagship therapeutic, GB-102, is an injectable microparticle formulation of sunitinib administered directly into the eye. This compound is progressing through Phase I/IIa and IIb clinical trials for wet age-related macular degeneration, while also undergoing Phase IIa trials for diabetic macular edema. Furthermore, GB-102 is being explored as a treatment for diabetic retinopathy. The company's pipeline also includes GB-401, an intraocular implant designed to deliver a beta-adrenergic receptor inhibitor, intended for the management of primary open-angle glaucoma. Initially established as Graybug LLC in 2011, the firm rebranded to Graybug Vision, Inc. in 2016 and is headquartered in Redwood City, California.

Key metrics

Market cap
$120.98M
P/E (TTM)
-0.27
EPS (TTM)
$-20.63
Beta
1.20
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$8.55
200-day avg
$11.51
52-week high
$20.30
52-week low
$4.88
CEO
Frederic Guerard

ETFs linked to GRAY

Broad-market and Healthcare sector ETFs an investor holding Graybug Vision is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how GRAY fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze GRAY in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Graybug Vision?
Graybug Vision trades under the ticker GRAY on NASDAQ.
Which exchange is GRAY listed on?
GRAY is listed on NASDAQ.
What sector does Graybug Vision operate in?
Graybug Vision is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze GRAY in a portfolio?
PortView shows GRAY's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.